Indication

High grade dysplasia associated with Barrett's esophagus

High-grade dysplasia associated with Barrett's esophagus is an advanced precancerous clinical state affecting the distal esophageal mucosa, typically arising as a complication of chronic gastroesophageal reflux disease. Read more about High grade dysplasia associated with Barrett's esophagus

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common High grade dysplasia associated with Barrett's esophagus therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with High grade dysplasia associated with Barrett's esophagus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About High grade dysplasia associated with Barrett's esophagus.

High-grade dysplasia associated with Barrett's esophagus is an advanced precancerous clinical state affecting the distal esophageal mucosa, typically arising as a complication of chronic gastroesophageal reflux disease.

In this condition, the normal stratified squamous epithelium that was previously replaced by specialized intestinal metaplasia undergoes severe neoplastic transformation confined within the epithelial basement membrane.

Histopathologically, it is characterized by marked architectural distortion—such as glandular crowding, branching, and cribriform patterns—alongside pronounced cytological atypia, including loss of nuclear polarity, hyperchromasia, pleomorphism, and atypical mitoses extending to the epithelial surface.

Because the dysplastic epithelium has not invaded the lamina propria, it represents noninvasive neoplasia (carcinoma in situ) that carries a substantially elevated risk of progressing to invasive esophageal adenocarcinoma.

Personalize your experience

Follow High grade dysplasia associated with Barrett's esophagus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it